期刊文献+

用Fugene6制作高滴度慢病毒方法的优化比较 被引量:2

The Optimized Protocol of Making High Titer Lentivirus by Using Fugene6
原文传递
导出
摘要 针对实验室中比较普遍的包装的慢病毒滴度不高的问题,我们对慢病毒包装过程中的几个关键步骤进行了优化。采用Fugene6同时转染携带GFP的质粒和包装慢病毒所必需的包装质粒进入293T细胞中。通过使用荧光显微观察GFP的表达亮度及流式细胞技术测量GFP阳性细胞的比例来测定病毒滴度。通过优化Fugene6和DNA的比例,发现当Fugene6和DNA的比例是3:1时获得的慢病毒的滴度最高;通过对转染后收获病毒的时间的比较,发现转染48小时后回收所得到的慢病毒滴度最高。 Lentivirus has been used widely as an exogenous gene delivery tool. However, it is relatively difficult to get high titer lentivirus. The purpose of this article was to modify two critical steps during the lentivirus packaging procedure in order to get high titer lentivirus. The two critical steps were the ratio between transfection agent and target vector, and the lentivirus collecting time. Fugene6 was used as the transfection agent. Plasmid car- rying green fluorescent protein (GFP) sequence was used as the target vector. Packaging plasmid, envelope plasmid and target vector were co-tranfected into the 293T ceils. The GFP positive 293T cells were visualize by fluorescence microscope. The percentage of GFP positive cells were analyzed by flow cytometry. We found that when the ratio of Fugene6 and target DNA was 3:1, the lentivirus titer was the highest comparing with other options. The lentivirus collected at 48 hours after transfection had the highest infection property.
出处 《中国细胞生物学学报》 CAS CSCD 2011年第4期385-390,共6页 Chinese Journal of Cell Biology
基金 上海市大学生创新计划(No.1500107029) 河北省医学科学研究重点课题计划(No.20100313)~~
关键词 慢病毒 滴度 Fugene6 lentivirus titer Fugene6
  • 相关文献

参考文献13

  • 1Salmon P, Trono D. Production and titration of lentiviral vectors. Curr Protoc Hum (3enet 2007, Chapter 4, unit4.21.
  • 2Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biot 1998; 9(5): 457-63.
  • 3Naldini L BU, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263- 7.
  • 4Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93(21): 11381-8.
  • 5Buchschaeher GL, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95(8): 2499-504.
  • 6Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R. Comparison of lentiviral vector titration methods. BMC Biotech- no12006; 6: 34.
  • 7Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Pro- toc 2009; 4(4): 495-505.
  • 8马海燕,方彧聃,张敬之.应用荧光实时定量PCR方法检测重组慢病毒滴度及其感染效率[J].生命科学研究,2009,13(5):394-398. 被引量:14
  • 9Geraerts M, Michiels M, Baekelandt V, Debyser Z, Gijsbers R. Upscaling of lentiviral vector production by tangential flow fil- tration. J Gene Med 2005; 7(10): 1299-310.
  • 10杨靖,宋波,赵国强,王茜,韩志强,许予明.慢病毒RNAi载体的制备及滴度测定方法的建立[J].中原医刊,2007,34(10):32-33. 被引量:2

二级参考文献24

  • 1张敬之,郭歆冰,谢书阳,朱怡文,黄英,王舒,任兆瑞.用慢病毒载体介导产生绿色荧光蛋白(GFP)转基因小鼠[J].自然科学进展,2006,16(5):571-577. 被引量:25
  • 2WU X, LI Y, CRISE B, et al. Transcription start regions in the human genome are favored targets for MLV integration[J]. Science, 2003,300: 1749-1751.
  • 3DEPALMA M, MONTINI E, SANTONIDESIO F R, et al. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells[J]. Blood, 2005,105(6): 2307-2315.
  • 4SCHRODER A R, SHINN P, CHEN H, et al. HIV-1 integration in the human genome favors active genes and local hotspots[J]. Cell, 2002, 110: 521-529.
  • 5JAKOBSSON J, ERICSON C, JANSSON M, et al. Targeted transgene expression in rat brain using lentiviral vectors[J]. Neurosci Res, 2003, 73(6): 876.
  • 6STEWART S A, OYLOCHOOM D M, PALLISER D, et al. Lentivims-delivered stable gene silencing by RNAi in primary cells[J]. RNA, 2003, 9(4): 493-501.
  • 7MAY C, RIVELLA S, CALLEGARI J, et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin[J]. Nature, 2000, 406 (6791): 82-86.
  • 8HAN X D, LIN C, CHANG J, et al. Fetal gene therapy of α-thalassemia in a mouse model[J]. PNAS, 2007, 104(21): 9007-9011.
  • 9LI W, XIE S Y, GUO X B, et al. A novel transgenic mouse model produced from lentiviral germline integration for the study of β-thalassemia gene therapy[J]. Haematologica, 2008, 93(3): 357-362.
  • 10LOIS C, HONG E J, PEASE S, et al. Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors[J]. Science, 2002, 295: 868-872.

共引文献14

同被引文献19

  • 1李华,刘维全,王太一,殷震.基因导入的脂质体转染法和磷酸钙转染法之比较[J].中国实验动物学杂志,2000,10(2):65-68. 被引量:14
  • 2陈晓,蒋捍东,路新枝,于文功.一种用磷酸钙法高效转染HEK293T细胞方法的建立[J].中国海洋大学学报(自然科学版),2005,35(5):807-810. 被引量:6
  • 3姚元虎,刘永彪,冯永,韩高华.聚乙烯亚胺转导效率与肿瘤细胞周期分布相关性分析[J].中国临床保健杂志,2006,9(3):207-209. 被引量:2
  • 4Briggs JAG,Wilk T,Fullwr SD. Do lipid rafts mediate virus assembly and pseudotyping[J].Journal of General Virology,2003,(04):757-768.
  • 5Connor RI,Chen BK,Choe S. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes[J].Virology,1995,(02):935-944.
  • 6Reed SE,Staley EM,Elizabeth M. Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors[J].Journal of Virological Methods,2006,(1/2):85-98.
  • 7Jacobsen LB,Calvin SA. FuGENE 6 Transfection Reagent:the gentle power[J].Methods:A Companion to Methods in Enzymology,2004,(02):104-112.
  • 8Siegert S,Thaler S,Wagner R. Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors[J].AIDS Research and Therapy,2005.7.
  • 9Brunner S,Fürtbauer E,Sauer T. Overcoming the nuclear barrier:cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation[J].Molecular Therapy,2002,(01):80-86.doi:10.1006/mthe.2001.0509.
  • 10GUO X, WANG W, HU J, et al. Lentivirus - mediated RNAi knockdown of NUPRI inhibits human nonsmall cell lung cancer growth in vitro and in vivo[ J]. Anat Rec (Hoboken) , 2012, 295 (12) :2114 -2121.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部